LAB DEVELOPMENT
ActiveSummary
The computed 12-month bankruptcy probability of LAB DEVELOPMENT is 7.7% (elevated). The 2025 annual accounts show negative equity (-€6,336) and a net result of -€1,293. Equity is shrinking by ~38.7% per year across the filed fiscal years. The company has been active since 2012 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-09
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 59 days late
12-05
KBO administration
Address struck
Imperiastraat 8 1930 L’adresse du siège Imperiastraat 8 1930 Die Sitzadresse Imperiastraat 8 1930
Zaventem werd doorgehaald met ingang van Zaventem · event 27-04-2026
2025
10-12
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 132 days late
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-12
Financial
Weakest financial yearnet -€3,283
Net result drops to -€3,283, the lowest in the series; recovery starts the following year.
13-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 44 days late
2022
31-12
Financial
Back to profitnet €477
Net result €477 after 3 loss-making years.
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
31-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 396 days late
2019
16-09
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 47 days late
2018
08-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 8 days late
2017
26-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
29-06
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
SignalFinancial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.